467 related articles for article (PubMed ID: 33200935)
1. Computational Design of 25-mer Peptide Binders of SARS-CoV-2.
Sitthiyotha T; Chunsrivirot S
J Phys Chem B; 2020 Dec; 124(48):10930-10942. PubMed ID: 33200935
[TBL] [Abstract][Full Text] [Related]
2. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.
Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401
[TBL] [Abstract][Full Text] [Related]
3. Designing peptides predicted to bind to the omicron variant better than ACE2 via computational protein design and molecular dynamics.
Sitthiyotha T; Treewattanawong W; Chunsrivirot S
PLoS One; 2023; 18(10):e0292589. PubMed ID: 37816037
[TBL] [Abstract][Full Text] [Related]
4. Computational redesign of Fab CC12.3 with substantially better predicted binding affinity to SARS-CoV-2 than human ACE2 receptor.
Treewattanawong W; Sitthiyotha T; Chunsrivirot S
Sci Rep; 2021 Nov; 11(1):22202. PubMed ID: 34772947
[TBL] [Abstract][Full Text] [Related]
5. Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors.
Sarma S; Herrera SM; Xiao X; Hudalla GA; Hall CK
J Phys Chem B; 2022 Oct; 126(41):8129-8139. PubMed ID: 36219223
[TBL] [Abstract][Full Text] [Related]
6. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
[TBL] [Abstract][Full Text] [Related]
9. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
[TBL] [Abstract][Full Text] [Related]
10. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
11. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
12. Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain.
Banerjee T; Gosai A; Yousefi N; Garibay OO; Seal S; Balasubramanian G
J Biomol Struct Dyn; 2024 Aug; 42(12):6342-6358. PubMed ID: 37424217
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
14. Tracing the driving forces responsible for the remarkable infectivity of 2019-nCoV: 1. Receptor binding domain in its bound and unbound states.
Liu Z; Xia M; Chai Z; Wang D
Phys Chem Chem Phys; 2020 Dec; 22(48):28277-28285. PubMed ID: 33295347
[TBL] [Abstract][Full Text] [Related]
15. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Peptides as Promising Therapeutics against SARS-CoV-2.
Chowdhury SM; Talukder SA; Khan AM; Afrin N; Ali MA; Islam R; Parves R; Al Mamun A; Sufian MA; Hossain MN; Hossain MA; Halim MA
J Phys Chem B; 2020 Nov; 124(44):9785-9792. PubMed ID: 33095007
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
[TBL] [Abstract][Full Text] [Related]
18. Corilagin and 1,3,6-Tri-
Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
[TBL] [Abstract][Full Text] [Related]
19. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
[TBL] [Abstract][Full Text] [Related]
20. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages.
Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
